NCT07514832 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515625 clinical trial report covering Sintilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515820 clinical trial report covering SHR-3821, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515469 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514767 clinical trial report covering Nivolumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514338 clinical trial report covering Napazimone, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515963 clinical trial report covering Irinotecan Hydrochloride Lioposome, Phase 2, endpoints, sponsor, geography, readout timing and development white

NCT07514858 clinical trial report covering Lu-AF28996, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07513285 clinical trial report covering Ibezapolstat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07513324 clinical trial report covering Pembrolizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07513454 clinical trial report covering HW211026, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261321 clinical trial report covering TM471-1, Phase 2, endpoints, sponsor, geography, readout timing and development white space.